31 January, 2015

Mebendazole: Another Extraordinary Cure For Cancer


Mebendazole: A Cheap But Effective Cancer Cure Mebendazole or better known as vermox is a deworming medication here in South Africa, used for children and dogs and cats. In the US mebendazole has been completely taken off the shelves, mebendazole cancer remedy is no longer even manufactured since they discovered that this inexpensive deworming medication mainly used by sheep farmers, is a powerful cancer killer. Our body defends itself against cancer cells and are usually destroyed before they can do damage. But for some people with cancer everyday is an ongoing struggle. There is good news. There exists a drug which many magazines have shown that it helps cure cancer. Without side effects. And Big Pharma hopes that you'll never hear about it. It's called mebendazole, in South Africa it is available without a prescription at the pharmacy. If you have kids you might recognize the drug brand names Vermox, Ovex, Antiox or Pripsen. It is usually used against worms. How Does Mebendazole Cancer Remedy Work? An important misconception is that a cell consists only of a nucleus and a cell wall, and that in all the cell (cytoplasm) is moving in a liquid or gel. However, the interior of a cell contains microtubules called spindles. This network of unyielding microtubules gives the cell its shape, structure and ability organelles and different molecules to other areas within the cell to bring about, so they basically act like a train track. The most vital function of these microtubules, cell division. The video below shows how microtubules work and reminds us how complex life is: Mebendazole cancer remedy disrupts the development of spindles so that cell division is prevented. The cell eventually die of old age or apoptosis. Mebendazole is highly selective and falls on the one or other way, only cancer cells (in addition to a whole series of intestinal parasites). The pharmaceutical industry has no interest in mebendazole. Big Pharma promote precisely the more toxic chemotherapy and related drugs because with mebendazole much less profit. What is cancer? It is generally assumed that after cell division produces two identical cells are formed. This is incorrect. DNA is not copied perfectly and usually occur in small errors. When a cell has too many errors in its DNA code, division cannot occur and die off errors in the cell. Over time, keeps the on cell division. With men this is after about 60 divisions. This is also known as the Hayflick limit. Biologists have discovered that are the subject of cancer cells to DNA-damaged cells with a code that the so-called telomer activates, so that the non cell dies. The Hayflick limit is endless. Because of the mutation, the cell is in fact immortal. A cancer cell is different from a healthy cell as it focuses on staying alive longer than normal cells despite it being a dysfunctional cell. Some studies have shown that mebendazole helps cure cancer: The Anthelmintic Drug Mebendazole Induces Apoptosis and mitotic Judgment by depolymerizing tubulin in Non-Small Cell Lung Cancer Cells, Ji-ichiro Sasaki, Rajagopal Ramesh, Sunil Chada, Yoshihito Gomyo, Jack A. Roth and Tapas Mukhopadhyay Molecular Cancer Therapy November 2002 1; 1201 Mebendazole elicits a Potent Antitumor Effect on Human Cancer Cell Lines in Vitro and in Vivo Both, Tapas Mukhopadhyay Ji-ichiro Sasaki, Rajagopal Ramesh, and Jack A. Roth, Clinical Cancer Research September 2002 8; 2963 Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells, Nicole Doudican, Adrianna Rodriguez, Iman Osman and Seth J. Orlow, Molecular Cancer Research, August 2008 6; 1308 Mebendazole Inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice, Daniele Martarelli, Pierluigi Pompei, Caterina Baldi and Giovanni Mazzoni, Cancer Chemotherapy and Pharmacology, volume 61, number 5, 809-817 Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma, Irina Y. Dobrosotskaya, MD, PhD, Gary D. Hammer, MD, David E. Schteingart, MD, Katherine E. fixtures, MD, Francis P. Worden, MD, Endocrine Practice, Volume 17, Number 3 / may-June 2011 Antiparasitic mebendazole shows survival benefit in two preclinical models of glioblastoma multiforme, Ren-Yuan Bai, Verena Staedtke Colette M. Aprhys, Gary L. Gallia and Gregory J. Riggins, Neuro-Oncology (2011) 13 (9): 974-982 Source: Viewzone.com

No comments: